Partnership to Make 120 Million COVID-19 Rapid Tests Available | Global Health | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Partnership to Make 120 Million COVID-19 Rapid Tests Available

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

A global partnership plans to make 120 million coronavirus disease 2019 (COVID-19) rapid antigen tests available in low- and middle-income countries, according to an announcement from the World Health Organization’s (WHO) Access to COVID-19 Tools Accelerator.

The easy-to-administer tests can provide results in 15 to 30 minutes and can be used outside of health care settings. Through an agreement with the Bill & Melinda Gates Foundation, Abbott and SD Biosensor will make the tests available at a cost of no more than $5 each. The WHO’s Global Fund has provided $50 million from its COVID-19 Response Mechanism to help countries begin purchasing the tests. The Africa Centres for Disease Control and Prevention and Unitaid, a nongovernmental organization, began a rollout of the tests in up to 20 African countries in October 2020. The WHO and the Foundation for Innovative New Diagnostics are supporting research to determine best practices for using the tests in low- and middle-income countries.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

A global partnership plans to make 120 million coronavirus disease 2019 (COVID-19) rapid antigen tests available in low- and middle-income countries, according to an announcement from the World Health Organization’s (WHO) Access to COVID-19 Tools Accelerator.

The easy-to-administer tests can provide results in 15 to 30 minutes and can be used outside of health care settings. Through an agreement with the Bill & Melinda Gates Foundation, Abbott and SD Biosensor will make the tests available at a cost of no more than $5 each. The WHO’s Global Fund has provided $50 million from its COVID-19 Response Mechanism to help countries begin purchasing the tests. The Africa Centres for Disease Control and Prevention and Unitaid, a nongovernmental organization, began a rollout of the tests in up to 20 African countries in October 2020. The WHO and the Foundation for Innovative New Diagnostics are supporting research to determine best practices for using the tests in low- and middle-income countries.

If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close